Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Mallinckrodt purchases pain drug Roxicodone from Xanodyne

Executive Summary

Continuing to strengthen its portfolio in preparation for a spin off from Covidien PLC’s Covidien Ltd., Mallinckrodt LLC (branded and generic pain and addiction treatments) has acquired Roxicodone (oxycodone, 5, 15, and 30 mg dosages) from Xanodyne Pharmaceuticals Inc. (formerly focused on pain management). The transaction includes all rights to the drug’s NDA.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase

Related Companies

UsernamePublicRestriction

Register